Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sulfur Dioxide Insertion. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed oxidative synthesis of aryl sulfonyl fluoride from hydrazine hydrochloride. Robust, air-tolerant process for reliable pharmaceutical intermediate supply.
Patent CN109553557B reveals a safe, metal-free route to thiosulfonates using DABSO. Ideal for reliable pharmaceutical intermediates supplier seeking cost-effective scaling.
Patent CN112047881B discloses a novel one-pot Grignard-SO2 insertion route for Tenapanor, eliminating palladium catalysts and toxic reagents for cost-effective API manufacturing.
Novel photochemical SO2 insertion method for 3-methylsulfonyl thioflavonoids. Mild conditions, high yield, oxidant-free process ideal for cost-effective pharmaceutical intermediate manufacturing.
Patent CN111517904A reveals a mild, catalyst-free method for sulfonylacetonitriles. This route offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.